Capital World InvestorsCapital World Investors

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings502 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

85.5M$29.1B5.6%$127.83+157.19%
17 qtrssince 2019-Q2
Decreased
0

BROADCOM INC

27.8M$24.1B4.6%$25.54+227.57%
17 qtrssince 2019-Q2
Increased
59

UNITEDHEALTH GROUP INC

29.2M$14B2.7%$230.77+96.94%
17 qtrssince 2019-Q2
Decreased
0

ELI LILLY & CO

26.9M$12.6B2.4%$223.81+104.83%
17 qtrssince 2019-Q2
Decreased
0

HOME DEPOT INC

39.1M$12.2B2.3%$197.54+46.48%
17 qtrssince 2019-Q2
Decreased
0

PHILIP MORRIS INTERNATIONAL

116.2M$11.3B2.2%$66.52+31.38%
17 qtrssince 2019-Q2
Increased
57

TESLA INC

42.3M$11.1B2.1%$216.90+18.72%
17 qtrssince 2019-Q2
Decreased
0

META PLATFORMS INC-CLASS A

37.1M$10.7B2.1%$211.19+32.38%
17 qtrssince 2019-Q2
Increased
57

CANADIAN NATURAL RESOURCES

148.9M$8.4B1.6%$15.37+64.66%
17 qtrssince 2019-Q2
Decreased
0

PFIZER INC

199M$7.3B1.4%$29.24+2.31%
17 qtrssince 2019-Q2
Decreased
0

APPLE INC

37.4M$7.3B1.4%$125.36+52.46%
17 qtrssince 2019-Q2
Increased
58

CATERPILLAR INC

28.8M$7.1B1.4%$186.95+25.56%
17 qtrssince 2019-Q2
Increased
50

THERMO FISHER SCIENTIFIC INC

12.9M$6.7B1.3%$298.52+71.00%
17 qtrssince 2019-Q2
Decreased
0

GILEAD SCIENCES INC

80.9M$6.2B1.2%$62.06+12.34%
17 qtrssince 2019-Q2
Increased
53

VERTEX PHARMACEUTICALS INC

17.3M$6.1B1.2%$232.41+49.81%
17 qtrssince 2019-Q2
Increased
54

ALPHABET INC-CL C

49.5M$6B1.2%$96.40+23.56%
17 qtrssince 2019-Q2
Decreased
0

JPMORGAN CHASE & CO

38.4M$5.6B1.1%$102.98+30.74%
17 qtrssince 2019-Q2
Decreased
0

APPLIED MATERIALS INC

36.7M$5.3B1.0%$101.80+38.54%
17 qtrssince 2019-Q2
Increased
56

NETFLIX INC

11.4M$5B1.0%$31.71+35.03%
17 qtrssince 2019-Q2
Increased
46

BOOKING HOLDINGS INC

1.8M$5B1.0%$81.69+29.47%
17 qtrssince 2019-Q2
Decreased
0
$519.9B
AUM
502
Positions
Q2 2023
Filing
Rating · 4.0
Quarterly Portfolio Change
-8%Q1'22$580.8B-19%Q2'22$470.7B-5%Q3'22$445.4B+5%Q4'22$469.1B+3%Q1'23$483.8B+7%Q2'23$519.9B
Activity profile
$ moved · Q2'23
New7%Increased48%Decreased40%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.0 years
<1Q5%1-4Q7%1-2Y11%2Y+77%

Capital World Investors manages $519.9B across 502 positions as of Q2 2023. Top holdings: MSFT (5.6%), AVGO (4.6%), UNH (2.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.

Q2 2023 Summary

Active quarter - 34 new positions, 44 exits, 188 increased. Top move: AVGO (INCREASED, conviction 59). Portfolio: $519.9B across 502 positions.

Top holdings by portfolio weight

Total AUM$520B
MSFT5.60%
AVGO4.64%
UNH2.70%
LLY2.42%
HD2.34%
PM2.18%
TSLA2.13%
META2.05%
CNQ1.61%
PFE1.40%
Other1.39%

Portfolio allocation by GICS sector

Sectors11
Technology21.28%
Healthcare16.53%
Consumer Cyclical12.49%
Financial Services10.36%
Industrials9.94%
Consumer Defensive7.68%
Communication Services6.49%
Energy6.47%
Basic Materials3.00%
Unknown2.94%
Other2.83%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Strong(4.0 / 5.0)
Track Record59
Conviction44
Concentration44
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
ESIESIELEMENT SOLUTIONS INC
Q3 2024 Q2 2026+1.7M shares+$124.1M
8Q
IONSIONSIONIS PHARMACEUTICALS INC
Q3 2024 Q2 2026+19.4M shares+$1.6B
8Q
NVRNVRNVR INC
Q3 2024 Q2 2026+564 shares-$27.4M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used